dc.contributor.author | Yaylim-Eraltan, Ilhan | |
dc.contributor.author | Yildiz, Yemliha | |
dc.contributor.author | Arıkan, Soykan | |
dc.contributor.author | Kucucuk, Seden | |
dc.contributor.author | Ergen, H. Arzu | |
dc.contributor.author | Isbir, Turgay | |
dc.date.accessioned | 2021-03-05T14:52:38Z | |
dc.date.available | 2021-03-05T14:52:38Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | Yildiz Y., Yaylim-Eraltan I., Arıkan S., Ergen H. A. , Kucucuk S., Isbir T., "Is there any correlation between TNF-related adoptosis-inducing ligand (TRAIL) genetic variants and breast cancer?", ARCHIVES OF MEDICAL SCIENCE, cilt.6, ss.932-936, 2010 | |
dc.identifier.issn | 1734-1922 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_b945bd94-fe17-416e-b9a3-b25561758ca6 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/123277 | |
dc.identifier.uri | https://doi.org/10.5114/aoms.2010.19304 | |
dc.description.abstract | Introduction: TNF-related apoptosis-inducing ligand (TRAIL) is a death ligand and also a member of the TNF superfamily. We aimed to investigate the possible relationship between TRAIL and breast cancer. Here, we report the results of the first association study on genetic variation in the TRAIL gene and its effect on breast cancer susceptibility and prognosis. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Temel Tıp Bilimleri | |
dc.title | Is there any correlation between TNF-related adoptosis-inducing ligand (TRAIL) genetic variants and breast cancer? | |
dc.type | Makale | |
dc.relation.journal | ARCHIVES OF MEDICAL SCIENCE | |
dc.contributor.department | Yeditepe Üniversitesi , , | |
dc.identifier.volume | 6 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 932 | |
dc.identifier.endpage | 936 | |
dc.contributor.firstauthorID | 64153 | |